Context Therapeutics: Anticipated CTIM-76 Ovarian Cancer Data as a Key Catalyst for CNTX Re-Rating
at www.tipranks.com (Thu, 23-Apr 8:25 AM)
Piper Sandler Reaffirms Their Buy Rating on Context Therapeutics (CNTX)
at www.tipranks.com (Tue, 21-Apr 7:29 AM)
